Zephyr AI is a company that provides AI-powered solutions for various industries. The company is committed to protecting user privacy and has a comprehensive privacy policy in place.

Jeff Sherman

Zephyr AI

BridgeBio Pharma is a self-described biopharmaceutical company focused on developing and commercializing transformative medicines for serious diseases. It focuses on gene-based and genetic medicine.

BridgeBio Pharma

Valo Therapeutics LTD is involved in cancer immunotherapy, focusing on pharmaceutical research, product development, and clinical research.

Valo Therapeutics LTD

Biogaran produces generic medications and health products, self-described as acting for health and accessibility.

Biogaran

Zephyr AI uses large complex data and proprietary algorithms to discover new insights and opportunities for Personalized/Precision Medicine, Drug Discovery, Drug Rescue, and Clinical Decision Support. Zephyr AI partners with leading health systems, health insurance plans, and biotechnology pioneers to improve Quality, Outcomes and Costs.

Metric
Company Name	Zephyr AI	BridgeBio Pharma	Valo Therapeutics LTD	Biogaran
Symbol
MSH ID	BIO:ZEPHYRAI	COM:BRIDGEBIOPHARMA	COM:VALOTX	FR:BIOGARAN
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Technology	Biotechnology	Pharmaceuticals	Pharmaceuticals
Country	US	US	FI	FR
Stage		Post-IPO Equity
Employee Count	51
Website	zephyrai.bio	bridgebiopharma.com	valotx.com	biogaran.fr
LinkedIn	zephyrai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.07K	23.81K
Web Traffic Growth	-0.76	0.19
Valuation
Raised Capital		250M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIO:ZEPHYRAI

Zephyr AI

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue